Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Prokidney has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 3 examiners across 2 art units, so the portfolio combines distinct examiner dockets with some art unit overlap.
SCHUBERG, LAURA J is the busiest examiner, with 1 pending matter. Responses should remain matter-specific, with art unit context considered when identifying recurring prosecution issues.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SCHUBERG, LAURA J | 1 | 23.9% | +37.1% |
| PAULUS, ERIN VIRGINIA | 1 | 19.0% | +94.4% |
| DIOP, FATIMATA SAHRA | 1 | 67.8% | +38.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17996571 | DEVICES AND SYSTEMS FOR DELIVERING THERAPEUTIC AGENTS | DIOP, FATIMATA SAHRA | 19d overdue |
| 18484426 | ISOLATED RENAL CELLS AND USES THEREOF | SCHUBERG, LAURA J | 70d |
| 18252619 | ENRICHED BIOACTIVE RENAL CELL POPULATIONS, CHARACTERISTICS AND USES THEREOF | PAULUS, ERIN VIRGINIA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17996571 | DEVICES AND SYSTEMS FOR DELIVERING THERAPEUTIC AGENTS | DIOP, FATIMATA SAHRA | 19d overdue |
| 18484426 | ISOLATED RENAL CELLS AND USES THEREOF | SCHUBERG, LAURA J | 70d |
| 18252619 | ENRICHED BIOACTIVE RENAL CELL POPULATIONS, CHARACTERISTICS AND USES THEREOF | PAULUS, ERIN VIRGINIA | — |
| Art Unit | Apps |
|---|---|
| 1631 | 2 |
| 3783 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18484426 | ISOLATED RENAL CELLS AND USES THEREOF | SCHUBERG, LAURA J | 1631 | §103 | Final Rejection | 70d | Pending | Oct 10, 2023 |
| 18252619 | ENRICHED BIOACTIVE RENAL CELL POPULATIONS, CHARACTERISTICS AND USES THEREOF | PAULUS, ERIN VIRGINIA | 1631 | §101§103§112DP | Final Rejection | — | Pending | May 11, 2023 |
| 17996571 | DEVICES AND SYSTEMS FOR DELIVERING THERAPEUTIC AGENTS | DIOP, FATIMATA SAHRA | 3783 | §102§103§112 | Non-Final OA | 19d overdue | Pending | Oct 19, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialProkidney has 3 pending office actions as of November 2026, spread across 2 art units and 3 examiners.
Laura J Schuberg has the most, with 1 of Prokidney's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.